Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and CNS remyelination
Natrajan, Muktha Sundar
Franklin, Robin J.M.
University of Cambridge
Department of Clinical Neuosciences
The Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute
John van Geest Centre for Brain Repair
Neuroimmunological Diseases Unit, National Institute of Neurological Disorders and Stroke (U.S.)
National Institutes of Health (U.S.)
MetadataShow full item record
Natrajan, M. S. (2015). Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and CNS remyelination (doctoral thesis).
Remyelination is a regenerative process that occurs through the formation of myelin sheaths by oligodendrocytes, which are recruited as oligodendrocyte progenitor cells (OPCs) after demyelination in diseases such as Multiple Sclerosis (MS).A key environmental factor regulating OPC differentiation is the fate of myelin debris generated during demyelination. Myelin debris contains inhibitors of OPC differentiation and thus its clearance by phagocytic macrophages is an important component of creating a lesion environment conducive to remyelination. The efficiency of debris clearance declines with age, contributing to the age-associated decline in remyelination. Therefore, understanding the mechanisms of the age-related decline in myelin debris phagocytosis is important for devising means to therapeutically reverse the decline in remyelination. The aim of this study was to determine the functional/molecular differences between young and old phagocytes involved in myelin debris clearance, thereby identifying therapeutically modifiable pathways associated with efficient myelin debris phagocytosis. In this study, we show that expression of genes involved in the retinoid X receptor (RXR) and peroxisome proliferator-activated receptor (PPAR) pathways are decreased with ageing in both myelin-phagocytosing human monocytes and mouse macrophages. Disruption of RXR and PPAR using synthetic antagonists in young macrophages mimics ageing by reducing myelin debris uptake. Macrophage-specific RXRα knockout mice revealed that loss of RXR function in young mice caused delayed myelin debris uptake and slowed remyelination. Alternatively, receptor agonists partially restored myelin debris phagocytosis in aged macrophages. The FDA-approved agonists bexarotene and pioglitazone, when used in concentrations achievable in human subjects, caused a reversion of the gene expression profiles in MS patient monocytes to a more youthful profile and enhanced myelin debris phagocytosis by patient cells. Activation of these pathways also enhances immunoregulatory markers on monocytes from MS patients, further suggesting the regeneration-promoting capacity of activating these pathways in phagocytes. These results reveal the RXR/PPAR pathway as a positive regulator of myelin debris clearance and a key player in the age-related decline in remyelination that may be targeted by available or newly-developed therapeutics.
Remyelination, Ageing, Multiple Sclerosis, Retinoid X Receptor, Myelin Debris, Monocyte-derived macrophages
This work was supported by the Gates-Cambridge Scholarship and NIH-Cambridge Partnership Program
This record's URL: https://www.repository.cam.ac.uk/handle/1810/252692
Attribution-NonCommercial-NoDerivs 2.0 UK: England & Wales
Licence URL: http://creativecommons.org/licenses/by-nc-nd/2.0/uk/
Recommended or similar items
The following licence files are associated with this item: